Sarissa Capital Acquisition Corp.
SRSA
NASDAQ Capital Market10.05
USD
- -
- -
CIK
0001821682
ISIN
KYG7823W1024
Return %
Stock
S&P500
1Y
2.45
18.21
3Y
-5.37
64.38
5Y
-5.37
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 660 Steamboat Road Greenwich CT United States of America 06830
- IPO Date
- Dec 11, 2020
- CIK
- 0001821682
- Similar Companies
- Business
- Sarissa Capital Acquisition Corp. (SRSA) is a blank check company, or special purpose acquisition company (SPAC), sponsored by Sarissa Capital Management LP, focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily in the healthcare or biotechnology sectors. The company has not yet completed an initial business combination and holds the majority of its assets in a trust account invested in U.S. government securities, money market funds, or cash equivalents; it offers no operating products or services beyond its pursuit of a de-SPAC transaction. Headquartered in Stamford, Connecticut, Sarissa Capital Acquisition Corp. was formed in 2021 and operates principally in the United States, targeting public market entry for innovative companies with strong clinical or commercial potential. No major recent changes, such as partnerships, funding rounds beyond its initial public offering, acquisitions, new product launches, strategic shifts, name changes, or operational expansions, have been publicly reported for the company within the last 1-2 years.